Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Teva Pharmaceuticals USA, Inc.”

12 pharma patents match "Teva Pharmaceuticals USA, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Teva Pharmaceuticals USA, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Teva Pharmaceuticals USA, Inc.” · 30,257 patents in full index Clear search

  1. US 11826322

    Pre-filled syringe

    Teva Pharmaceuticals USA, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted

  2. US 10835503

    Pre-filled syringe

    Teva Pharmaceuticals USA, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  3. US 10640487

    Solid state forms of Nilotinib salts

    Teva Pharmaceuticals USA, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  4. US 10035802

    Solid state forms of ibrutinib

    Teva Pharmaceuticals USA, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  5. US 8609856

    Crystalline forms of Febuxostat

    Teva Pharmaceuticals USA, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  6. US 8415481

    Crystalline form of febuxostat

    Teva Pharmaceuticals USA, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  7. US 8222282

    Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine

    Teva Pharmaceuticals USA, Inc. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

  8. US 7531656

    Synthesis of gatifloxacin

    Teva Pharmaceuticals USA, Inc. · Granted May 12, 2009 · Expires May 7, 2029

    granted

  9. US 7456207

    Vaginal pharmaceutical compositions and methods for preparing them

    Teva Pharmaceuticals USA, Inc. · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  10. US 7396839

    Crystalline forms of gatifloxacin

    Teva Pharmaceuticals USA, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted

  11. US 6306436

    Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

    Teva Pharmaceuticals USA, Inc. · Granted Oct 23, 2001 · Expires Oct 18, 2021

    expired

  12. US 6017531

    Hydrophilic composition containing protease produced by Vibrio

    Conn. / Teva Pharmaceuticals USA, Inc. · Granted Jan 25, 2000 · Expires Jan 20, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.